Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis.
Ruplizumab (trade name Antova) is a type of treatment for rheumatic diseases, including systemic lupus erythematosus and lupus nephritis, which are similar to autoimmune disorders.